 |
|
| ADVANCES IN ANTIVIRAL DRUG DESIGN, 5
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
E. De Clercq, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
Included in series
Advances in Antiviral Drug Design,
Description
Regularly reviewing the "state-of-the-art" developments in the antiviral drug research field, this latest volume spans the conceptual
design and chemical synthesis of new antiviral compounds. It discusses their structure-activity relationship, mechanism and targets of
action, pharmacological behavior, antiviral activity spectrum, and therapeutic potential for clinical use.
Audience
Researchers, academics and postgraduates working in medical virology and infectious diseases, chemotherapy and drug discovery
Contents
Status presens of antiviral drugs and strategies, Part I: DNA viruses and retroviruses
Status presens of antiviral drugs and strategies,
Part II: RNA viruses (except retroviruses)
Methylenecyclopropane analogues of nucleosides as anti-herpes agents
Synthesis and antiviral
evaluation of broad spectrum orally active analogs of cidofovir and other acyclic nucleoside phosphonates
CCR5 antagonists for the treatment
of HIV infection and AIDS
The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors
(NNRTIs)
| Bibliographic details |
Hardbound, 264 pages, publication date: JUL-2007
ISBN-13: 978-0-444-52173-6
ISBN-10: 0-444-52173-9
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 87
USD 140
EUR 102.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
092/943
Last update: 22 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company